233 related articles for article (PubMed ID: 16638752)
21. Characterization of the DNA polymerase gene of varicella-zoster viruses resistant to acyclovir.
Kamiyama T; Kurokawa M; Shiraki K
J Gen Virol; 2001 Nov; 82(Pt 11):2761-2765. PubMed ID: 11602787
[TBL] [Abstract][Full Text] [Related]
22. Two-Metal Ion-Dependent Enzymes as Potential Antiviral Targets in Human Herpesviruses.
DiScipio KA; Weerasooriya S; Szczepaniak R; Hazeen A; Wright LR; Wright DL; Weller SK
mBio; 2022 Feb; 13(1):e0322621. PubMed ID: 35073739
[TBL] [Abstract][Full Text] [Related]
23. Secondary structure and structure-activity relationships of peptides corresponding to the subunit interface of herpes simplex virus DNA polymerase.
Bridges KG; Hua Q; Brigham-Burke MR; Martin JD; Hensley P; Dahl CE; Digard P; Weiss MA; Coen DM
J Biol Chem; 2000 Jan; 275(1):472-8. PubMed ID: 10617641
[TBL] [Abstract][Full Text] [Related]
24. Novel targets for the development of anti-herpes compounds.
Greco A; Diaz JJ; Thouvenot D; Morfin F
Infect Disord Drug Targets; 2007 Mar; 7(1):11-8. PubMed ID: 17346207
[TBL] [Abstract][Full Text] [Related]
25. A mutation in the human herpes simplex virus type 1 UL52 zinc finger motif results in defective primase activity but can recruit viral polymerase and support viral replication efficiently.
Chen Y; Livingston CM; Carrington-Lawrence SD; Bai P; Weller SK
J Virol; 2007 Aug; 81(16):8742-51. PubMed ID: 17553899
[TBL] [Abstract][Full Text] [Related]
26. [Prevention and therapy of herpesvirus infections].
Abb J
Zentralbl Bakteriol Mikrobiol Hyg B; 1985 Feb; 180(2-3):107-20. PubMed ID: 2986378
[TBL] [Abstract][Full Text] [Related]
27. The catalytic subunit of herpes simplex virus type 1 DNA polymerase contains a nuclear localization signal in the UL42-binding region.
Loregian A; Piaia E; Cancellotti E; Papini E; Marsden HS; Palù G
Virology; 2000 Jul; 273(1):139-48. PubMed ID: 10891416
[TBL] [Abstract][Full Text] [Related]
28. Herpes simplex virus helicase-primase inhibitors are active in animal models of human disease.
Crute JJ; Grygon CA; Hargrave KD; Simoneau B; Faucher AM; Bolger G; Kibler P; Liuzzi M; Cordingley MG
Nat Med; 2002 Apr; 8(4):386-91. PubMed ID: 11927945
[TBL] [Abstract][Full Text] [Related]
29. The enhanced DNA replication fidelity of a mutant herpes simplex virus type 1 DNA polymerase is mediated by an improved nucleotide selectivity and reduced mismatch extension ability.
Tian W; Hwang YT; Hwang CB
J Virol; 2008 Sep; 82(17):8937-41. PubMed ID: 18596099
[TBL] [Abstract][Full Text] [Related]
30. Herpesvirus DNA polymerases: Structures, functions and inhibitors.
Zarrouk K; Piret J; Boivin G
Virus Res; 2017 Apr; 234():177-192. PubMed ID: 28153606
[TBL] [Abstract][Full Text] [Related]
31. Mutations in the Exo III motif of the herpes simplex virus DNA polymerase gene can confer altered drug sensitivities.
Hwang YT; Smith JF; Gao L; Hwang CB
Virology; 1998 Jul; 246(2):298-305. PubMed ID: 9657948
[TBL] [Abstract][Full Text] [Related]
32. An importin alpha/beta-recognized bipartite nuclear localization signal mediates targeting of the human herpes simplex virus type 1 DNA polymerase catalytic subunit pUL30 to the nucleus.
Alvisi G; Musiani D; Jans DA; Ripalti A
Biochemistry; 2007 Aug; 46(32):9155-63. PubMed ID: 17640102
[TBL] [Abstract][Full Text] [Related]
33. Mutational analysis of DNA polymerase substrate recognition and subunit interactions using herpes simplex virus as prototype.
Digard P; Bebrin WR; Coen DM
Methods Enzymol; 1995; 262():303-22. PubMed ID: 8594357
[No Abstract] [Full Text] [Related]
34. Guanine α-carboxy nucleoside phosphonate (G-α-CNP) shows a different inhibitory kinetic profile against the DNA polymerases of human immunodeficiency virus (HIV) and herpes viruses.
Balzarini J; Menni M; Das K; van Berckelaer L; Ford A; Maguire NM; Liekens S; Boehmer PE; Arnold E; Götte M; Maguire AR
Biochem Pharmacol; 2017 Jul; 136():51-61. PubMed ID: 28390939
[TBL] [Abstract][Full Text] [Related]
35. Psoromic Acid, a Lichen-Derived Molecule, Inhibits the Replication of HSV-1 and HSV-2, and Inactivates HSV-1 DNA Polymerase: Shedding Light on Antiherpetic Properties.
Hassan STS; Šudomová M; Berchová-Bímová K; Šmejkal K; Echeverría J
Molecules; 2019 Aug; 24(16):. PubMed ID: 31405197
[TBL] [Abstract][Full Text] [Related]
36. Identifying the features of purine dNTPs that allow accurate and efficient DNA replication by herpes simplex virus I DNA polymerase.
Cavanaugh NA; Urban M; Beckman J; Spratt TE; Kuchta RD
Biochemistry; 2009 Apr; 48(15):3554-64. PubMed ID: 19166354
[TBL] [Abstract][Full Text] [Related]
37. Association of the Emergence of Acyclovir-Resistant Herpes Simplex Virus Type 1 With Prognosis in Hematopoietic Stem Cell Transplantation Patients.
Kakiuchi S; Tsuji M; Nishimura H; Yoshikawa T; Wang L; Takayama-Ito M; Kinoshita H; Lim CK; Fujii H; Yamada S; Harada S; Oka A; Mizuguchi M; Taniguchi S; Saijo M
J Infect Dis; 2017 Mar; 215(6):865-873. PubMed ID: 28453848
[TBL] [Abstract][Full Text] [Related]
38. [Contribution of the laboratory in case of resistance to acyclovir of herpes simplex and varicella zoster virus].
Morfin F; Frobert E; Thouvenot D
Ann Biol Clin (Paris); 2003; 61(1):33-40. PubMed ID: 12604384
[TBL] [Abstract][Full Text] [Related]
39. The crystal structure of an unusual processivity factor, herpes simplex virus UL42, bound to the C terminus of its cognate polymerase.
Zuccola HJ; Filman DJ; Coen DM; Hogle JM
Mol Cell; 2000 Feb; 5(2):267-78. PubMed ID: 10882068
[TBL] [Abstract][Full Text] [Related]
40. Genotypic characterization of the DNA polymerase and sensitivity to antiviral compounds of foscarnet-resistant herpes simplex virus type 1 (HSV-1) derived from a foscarnet-sensitive HSV-1 strain.
Saijo M; Suzutani T; Morikawa S; Kurane I
Antimicrob Agents Chemother; 2005 Feb; 49(2):606-11. PubMed ID: 15673740
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
